Interested in scooping proteins from subcellular regions of your cancer research sample and identifying novel protein constituents for your problem of interest?
Microscopic scooping with Syncell’s Microscoop® technology has been used to identify novel protein components for triple negative breast cancer as well as immune synapses between cancer cells and T cells. Imagine that you can isolate and identify proteins close to vimentin, immunotherapy drug pembrolizumab, macrophage-cancer cell interface, tumor-derived extracellular vesicles, or your problem of interest. It will be great to study further and reveal novel factors associated with tumor cell processes and shed light on potential new cancer drug targets.
Attending the AACR this April?
If so, we invite you to stop by booth 1651 and know more about Syncell’s Microscoop®.
1. Exhibition Booth #1651
2. Poster Session:
- Title: Identification of the novel immune synapse-localized proteome for immuno-oncology using Microscoop-induced targeted photo-biotinylation.
- Time: 1:30PM – 5:00PM, Sunday, April 7th, 2024
- Board No: 23
